3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
6
Neoplasms
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Cognitive Dysfunction
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Interventions
Surveys and Questionnaires
7
COVID-19 Vaccines
4
Surgical Procedures, Operative
3
Specimen Handling
3
Blood Specimen Collection
3
Pandemic Preparedness
2
Data Collection
2
BNT162 Vaccine
2
2019-nCoV Vaccine mRNA-1273
2
sinovac COVID-19 vaccine
1
regorafenib
1
heterologous prime boost COVID-19 vaccination
1
Telemedicine
1
Sorafenib
1
Serologic Tests
1
Patient Reported Outcome Measures
1
Meopa
1
Mastectomy, Segmental
1
High-Throughput Nucleotide Sequencing
1
Drug Therapy
1
Colonoscopy
1
Ad26COVS1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
COVID-19
×
Patient Reported Outcome Measures
×
Clear all
NCT05831787
2026-05-18
COSMIC
ASH Research Collaborative
Completed
201 enrolled
15 charts